カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のアトピー性皮膚炎治療薬市場2022年：注射剤、経口剤、熱帯剤

◆英語タイトル：Global Atopic Dermatitis Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8743）◆商品コード：GIR22MY8743
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：95
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アトピー性皮膚炎治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアトピー性皮膚炎治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アトピー性皮膚炎治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・注射剤、経口剤、熱帯剤

用途別セグメントは次のように区分されます。
・病院、クリニック

世界のアトピー性皮膚炎治療薬市場の主要な市場プレーヤーは以下のとおりです。
・LEO Pharma、Mylan、Valeant、Bayer HealthCare、Encore Dermatology

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アトピー性皮膚炎治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアトピー性皮膚炎治療薬メーカーの企業概要、2019年～2022年までのアトピー性皮膚炎治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアトピー性皮膚炎治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アトピー性皮膚炎治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアトピー性皮膚炎治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアトピー性皮膚炎治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアトピー性皮膚炎治療薬の産業チェーンを掲載しています。
・第13、14、15章では、アトピー性皮膚炎治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：LEO Pharma、Mylan、Valeant、Bayer HealthCare、Encore Dermatology
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：注射剤、経口剤、熱帯剤
・用途別分析2017年-2028年：病院、クリニック
・アトピー性皮膚炎治療薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・アトピー性皮膚炎治療薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・アトピー性皮膚炎治療薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・アトピー性皮膚炎治療薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・アトピー性皮膚炎治療薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Atopic Dermatitis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Atopic Dermatitis Drugs market size is estimated to be worth US$ 5563.3 million in 2021 and is forecast to a readjusted size of USD 7584.4 million by 2028 with a CAGR of 4.5% during review period. Hospital accounting for % of the Atopic Dermatitis Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injectable segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Atopic Dermatitis Drugs include LEO Pharma, Mylan, Valeant, Bayer HealthCare, and Encore Dermatology, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Atopic Dermatitis Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injectable
Oral
Tropical
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Atopic Dermatitis Drugs market are listed below:
LEO Pharma
Mylan
Valeant
Bayer HealthCare
Encore Dermatology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atopic Dermatitis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Atopic Dermatitis Drugs, with price, sales, revenue and global market share of Atopic Dermatitis Drugs from 2019 to 2022.
Chapter 3, the Atopic Dermatitis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atopic Dermatitis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Atopic Dermatitis Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Atopic Dermatitis Drugs.
Chapter 13, 14, and 15, to describe Atopic Dermatitis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Atopic Dermatitis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Atopic Dermatitis Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Injectable
1.2.3 Oral
1.2.4 Tropical
1.3 Market Analysis by Application
1.3.1 Overview: Global Atopic Dermatitis Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Atopic Dermatitis Drugs Market Size & Forecast
1.4.1 Global Atopic Dermatitis Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Atopic Dermatitis Drugs Sales in Volume (2017-2028)
1.4.3 Global Atopic Dermatitis Drugs Price (2017-2028)
1.5 Global Atopic Dermatitis Drugs Production Capacity Analysis
1.5.1 Global Atopic Dermatitis Drugs Total Production Capacity (2017-2028)
1.5.2 Global Atopic Dermatitis Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Atopic Dermatitis Drugs Market Drivers
1.6.2 Atopic Dermatitis Drugs Market Restraints
1.6.3 Atopic Dermatitis Drugs Trends Analysis
2 Manufacturers Profiles
2.1 LEO Pharma
2.1.1 LEO Pharma Details
2.1.2 LEO Pharma Major Business
2.1.3 LEO Pharma Atopic Dermatitis Drugs Product and Services
2.1.4 LEO Pharma Atopic Dermatitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Atopic Dermatitis Drugs Product and Services
2.2.4 Mylan Atopic Dermatitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Valeant
2.3.1 Valeant Details
2.3.2 Valeant Major Business
2.3.3 Valeant Atopic Dermatitis Drugs Product and Services
2.3.4 Valeant Atopic Dermatitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bayer HealthCare
2.4.1 Bayer HealthCare Details
2.4.2 Bayer HealthCare Major Business
2.4.3 Bayer HealthCare Atopic Dermatitis Drugs Product and Services
2.4.4 Bayer HealthCare Atopic Dermatitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Encore Dermatology
2.5.1 Encore Dermatology Details
2.5.2 Encore Dermatology Major Business
2.5.3 Encore Dermatology Atopic Dermatitis Drugs Product and Services
2.5.4 Encore Dermatology Atopic Dermatitis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Atopic Dermatitis Drugs Breakdown Data by Manufacturer
3.1 Global Atopic Dermatitis Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Atopic Dermatitis Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Atopic Dermatitis Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Atopic Dermatitis Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Atopic Dermatitis Drugs Manufacturer Market Share in 2021
3.5 Global Atopic Dermatitis Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Atopic Dermatitis Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Atopic Dermatitis Drugs Market Size by Region
4.1.1 Global Atopic Dermatitis Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Atopic Dermatitis Drugs Revenue by Region (2017-2028)
4.2 North America Atopic Dermatitis Drugs Revenue (2017-2028)
4.3 Europe Atopic Dermatitis Drugs Revenue (2017-2028)
4.4 Asia-Pacific Atopic Dermatitis Drugs Revenue (2017-2028)
4.5 South America Atopic Dermatitis Drugs Revenue (2017-2028)
4.6 Middle East and Africa Atopic Dermatitis Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Atopic Dermatitis Drugs Sales in Volume by Type (2017-2028)
5.2 Global Atopic Dermatitis Drugs Revenue by Type (2017-2028)
5.3 Global Atopic Dermatitis Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Atopic Dermatitis Drugs Sales in Volume by Application (2017-2028)
6.2 Global Atopic Dermatitis Drugs Revenue by Application (2017-2028)
6.3 Global Atopic Dermatitis Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Atopic Dermatitis Drugs Sales by Type (2017-2028)
7.2 North America Atopic Dermatitis Drugs Sales by Application (2017-2028)
7.3 North America Atopic Dermatitis Drugs Market Size by Country
7.3.1 North America Atopic Dermatitis Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Atopic Dermatitis Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Atopic Dermatitis Drugs Sales by Type (2017-2028)
8.2 Europe Atopic Dermatitis Drugs Sales by Application (2017-2028)
8.3 Europe Atopic Dermatitis Drugs Market Size by Country
8.3.1 Europe Atopic Dermatitis Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Atopic Dermatitis Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Atopic Dermatitis Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Atopic Dermatitis Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Atopic Dermatitis Drugs Market Size by Region
9.3.1 Asia-Pacific Atopic Dermatitis Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Atopic Dermatitis Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Atopic Dermatitis Drugs Sales by Type (2017-2028)
10.2 South America Atopic Dermatitis Drugs Sales by Application (2017-2028)
10.3 South America Atopic Dermatitis Drugs Market Size by Country
10.3.1 South America Atopic Dermatitis Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Atopic Dermatitis Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Atopic Dermatitis Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Atopic Dermatitis Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Atopic Dermatitis Drugs Market Size by Country
11.3.1 Middle East & Africa Atopic Dermatitis Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Atopic Dermatitis Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Atopic Dermatitis Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Atopic Dermatitis Drugs
12.3 Atopic Dermatitis Drugs Production Process
12.4 Atopic Dermatitis Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Atopic Dermatitis Drugs Typical Distributors
13.3 Atopic Dermatitis Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Atopic Dermatitis Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Atopic Dermatitis Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 4. LEO Pharma Major Business
Table 5. LEO Pharma Atopic Dermatitis Drugs Product and Services
Table 6. LEO Pharma Atopic Dermatitis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Mylan Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Major Business
Table 9. Mylan Atopic Dermatitis Drugs Product and Services
Table 10. Mylan Atopic Dermatitis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Valeant Basic Information, Manufacturing Base and Competitors
Table 12. Valeant Major Business
Table 13. Valeant Atopic Dermatitis Drugs Product and Services
Table 14. Valeant Atopic Dermatitis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 16. Bayer HealthCare Major Business
Table 17. Bayer HealthCare Atopic Dermatitis Drugs Product and Services
Table 18. Bayer HealthCare Atopic Dermatitis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Encore Dermatology Basic Information, Manufacturing Base and Competitors
Table 20. Encore Dermatology Major Business
Table 21. Encore Dermatology Atopic Dermatitis Drugs Product and Services
Table 22. Encore Dermatology Atopic Dermatitis Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Atopic Dermatitis Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Atopic Dermatitis Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Atopic Dermatitis Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Atopic Dermatitis Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Atopic Dermatitis Drugs Production Site of Key Manufacturer
Table 28. Atopic Dermatitis Drugs New Entrant and Capacity Expansion Plans
Table 29. Atopic Dermatitis Drugs Mergers & Acquisitions in the Past Five Years
Table 30. Global Atopic Dermatitis Drugs Sales by Region (2017-2022) & (K Units)
Table 31. Global Atopic Dermatitis Drugs Sales by Region (2023-2028) & (K Units)
Table 32. Global Atopic Dermatitis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Atopic Dermatitis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)
Table 35. Global Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)
Table 36. Global Atopic Dermatitis Drugs Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Atopic Dermatitis Drugs Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Atopic Dermatitis Drugs Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Atopic Dermatitis Drugs Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Global Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)
Table 42. Global Atopic Dermatitis Drugs Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Atopic Dermatitis Drugs Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Atopic Dermatitis Drugs Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Atopic Dermatitis Drugs Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Atopic Dermatitis Drugs Sales by Country (2017-2022) & (K Units)
Table 47. North America Atopic Dermatitis Drugs Sales by Country (2023-2028) & (K Units)
Table 48. North America Atopic Dermatitis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Atopic Dermatitis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)
Table 51. North America Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)
Table 52. North America Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)
Table 53. North America Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Europe Atopic Dermatitis Drugs Sales by Country (2017-2022) & (K Units)
Table 55. Europe Atopic Dermatitis Drugs Sales by Country (2023-2028) & (K Units)
Table 56. Europe Atopic Dermatitis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Atopic Dermatitis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Europe Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Atopic Dermatitis Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Atopic Dermatitis Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Atopic Dermatitis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Atopic Dermatitis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)
Table 70. South America Atopic Dermatitis Drugs Sales by Country (2017-2022) & (K Units)
Table 71. South America Atopic Dermatitis Drugs Sales by Country (2023-2028) & (K Units)
Table 72. South America Atopic Dermatitis Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Atopic Dermatitis Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)
Table 75. South America Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)
Table 76. South America Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)
Table 77. South America Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Atopic Dermatitis Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Atopic Dermatitis Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Atopic Dermatitis Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Atopic Dermatitis Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Atopic Dermatitis Drugs Raw Material
Table 87. Key Manufacturers of Atopic Dermatitis Drugs Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Atopic Dermatitis Drugs Typical Distributors
Table 91. Atopic Dermatitis Drugs Typical Customers
List of Figures
Figure 1. Atopic Dermatitis Drugs Picture
Figure 2. Global Atopic Dermatitis Drugs Revenue Market Share by Type in 2021
Figure 3. Injectable
Figure 4. Oral
Figure 5. Tropical
Figure 6. Global Atopic Dermatitis Drugs Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Global Atopic Dermatitis Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Atopic Dermatitis Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Atopic Dermatitis Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Atopic Dermatitis Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Atopic Dermatitis Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Atopic Dermatitis Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Atopic Dermatitis Drugs Market Drivers
Figure 16. Atopic Dermatitis Drugs Market Restraints
Figure 17. Atopic Dermatitis Drugs Market Trends
Figure 18. Global Atopic Dermatitis Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Atopic Dermatitis Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Atopic Dermatitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Atopic Dermatitis Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Atopic Dermatitis Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Atopic Dermatitis Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Atopic Dermatitis Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Atopic Dermatitis Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Atopic Dermatitis Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Atopic Dermatitis Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Atopic Dermatitis Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Atopic Dermatitis Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Atopic Dermatitis Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Atopic Dermatitis Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Atopic Dermatitis Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Atopic Dermatitis Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Atopic Dermatitis Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Atopic Dermatitis Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Atopic Dermatitis Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Atopic Dermatitis Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Atopic Dermatitis Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Atopic Dermatitis Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Atopic Dermatitis Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Atopic Dermatitis Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Atopic Dermatitis Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Atopic Dermatitis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Atopic Dermatitis Drugs in 2021
Figure 77. Manufacturing Process Analysis of Atopic Dermatitis Drugs
Figure 78. Atopic Dermatitis Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のアトピー性皮膚炎治療薬市場2022年：注射剤、経口剤、熱帯剤(Global Atopic Dermatitis Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • イロプロスト薬の世界市場見通し2023年-2029年
  • アトピー性皮膚炎薬の世界市場2022年～2029年：クラス別、投与経路別、地域別
  • 世界のイソトレチノイン薬市場2022年：カプセル、注射
  • 世界の先端巨大症・巨人症治療薬市場2022年：ソマトスタチン類似体、GH受容体拮抗薬、ドーパミン作動薬、組換えヒトIGF-1
  • 世界の血漿製剤市場2022年：免疫グロブリン、アルブミン、凝固因子、その他